| pubmed-article:11107147 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11107147 | lifeskim:mentions | umls-concept:C0027819 | lld:lifeskim |
| pubmed-article:11107147 | lifeskim:mentions | umls-concept:C0034606 | lld:lifeskim |
| pubmed-article:11107147 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:11107147 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:11107147 | lifeskim:mentions | umls-concept:C1533716 | lld:lifeskim |
| pubmed-article:11107147 | lifeskim:mentions | umls-concept:C1999230 | lld:lifeskim |
| pubmed-article:11107147 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:11107147 | pubmed:dateCreated | 2001-2-2 | lld:pubmed |
| pubmed-article:11107147 | pubmed:abstractText | High-affinity somatostatin receptors (SRs) have been characterized in neuroblastomas and may be used as target structures for in vivo detection of SR. | lld:pubmed |
| pubmed-article:11107147 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11107147 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11107147 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11107147 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11107147 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11107147 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11107147 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11107147 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11107147 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11107147 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11107147 | pubmed:issn | 0098-1532 | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:JacobssonHH | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:BorgströmPP | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:SchwarzKK | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:TreunerJJ | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:MartinssonTT | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:AmbrosP FPF | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:KognerPP | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:SchillingF... | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:BihlHH | lld:pubmed |
| pubmed-article:11107147 | pubmed:author | pubmed-author:AmbrosI MIM | lld:pubmed |
| pubmed-article:11107147 | pubmed:copyrightInfo | Copyright 2000 Wiley-Liss, Inc. | lld:pubmed |
| pubmed-article:11107147 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11107147 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:11107147 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11107147 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11107147 | pubmed:pagination | 688-91 | lld:pubmed |
| pubmed-article:11107147 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:meshHeading | pubmed-meshheading:11107147... | lld:pubmed |
| pubmed-article:11107147 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11107147 | pubmed:articleTitle | Combined (111)In-pentetreotide scintigraphy and (123)I-mIBG scintigraphy in neuroblastoma provides prognostic information. | lld:pubmed |
| pubmed-article:11107147 | pubmed:affiliation | Oncology/Hematology/Immunology, Olgahospital, Childhood and Adolescent Health, Stuttgart, Germany. fhs@nbs.s.shuttle.de | lld:pubmed |
| pubmed-article:11107147 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11107147 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11107147 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11107147 | lld:pubmed |
